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Abstract
Previously, we demonstrated that loss of SEMA3F, a
secreted semaphorin encoded in 3p21.3, is associated
with higher stages in lung cancer and primary tumor
cells studied with anti–vascular endothelial growth
factor (VEGF) and SEMA3F antibodies. In vitro,
SEMA3F inhibits cell spreading; this activity is op-
posed by VEGF. These results suggest that VEGF and
SEMA3F compete for binding to their common neuro-
pilin receptor. In the present report, we investi-
gated the attractive/repulsive effects of SEMA3F on
cell migration when cells were grown in a three-
dimensional system and exposed to a SEMA3F gra-
dient. In addition, we adapted the neurobiologic stripe
assay to analyze the migration of tumor cells in
response to SEMA3F. In the motile breast cancer cell
line C100, which expresses both neuropilin-1 (NRP1)
and neuropilin-2 (NRP2) receptors, SEMA3F had a
repulsive effect, which was blocked by anti-NRP2
antibody. In less motile MCF7 cells, which express
only NRP1, SEMA3F inhibited cell contacts with loss of
membrane-associated E-cadherin and B-catenin with-
out motility induction. Cell spreading and proliferation
were reduced. These results support the concept that
in a first step during tumorigenesis, normal tissues
expressing SEMA3F would try to prevent tumor cells
from spreading and attaching to the stroma for further
implantation.
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Introduction
Class 3 semaphorins, including SEMA3F [1], are a family of
secreted molecules initially identified on the basis that they
cause collapse of nerve growth cones [2]. However, these
semaphorins are widely expressed outside the central ner-
vous system, consistent with additional functions. Neuro-
pilin-1 (NRP1) and neuropilin-2 (NRP2) were identified as
high-affinity semaphorin receptors [3,4]. More recently,
these receptors have been shown to associate with and
require Plexin A for signaling [5]. In addition, the adhesion
molecule L1-CAM [6,7] and integrins [8] could be part of the
complex. Interestingly, the neuropilins were independently
identified as coreceptors in endothelial cells for vascular endo-
thelial growth factor (VEGF)165 [9]. The prototype class 3
semaphorin, Sema3A (collapsin), was shown to block VEGF-
induced motility and lamellipodia formation [10]. Similarly, we
demonstrated that SEMA3F and VEGF had reciprocal immu-
nostaining patterns in primary lung cancer cells [11] and, in
breast cancer cell lines SEMA3F and VEGF, had opposing
NRP-dependent effects on cell attachment and spreading [12].
Together, these results suggest that class 3 semaphorins
either compete with VEGF for NRP binding, or bind distinctly
with opposing actions.
Both SEMA3F and SEMA3B map to 3p21.3, a region of
frequent loss in lung and breast cancers [13–15]. In primary
lung tumor cells, antibody staining for SEMA3F correlates with
both tumor stage and histologic subtypes [11], and loss of
SEMA3F is an early event in lung cancer development [16].
SEMA3F expression inhibits mouse fibrosarcoma A9 cell tu-
morigenicity [17] as well as HEK 293–induced tumors [18].
Similarly, transfection of SEMA3B inhibited in vitro colony
formation by NCI-H1299 lung cancer cells [19] and tumorigene-
sis of HEY ovarian adenocarcinoma cells [20]. Thus, SEMA3F
and SEMA3B demonstrate clear antitumor activity.
During normal axon development, semaphorins exert di-
rectional effects due to concentration gradients [21]. In the
present report, which is an extension of our previous work, we
have studied the effects of SEMA3F on tumor cell migration
using both three-dimensional cocultures with a unidirectional
SEMA3F gradient, as well as the stripe assay in which cells can
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migrate to either SEMA3F-positive or SEMA3F-negative
segments. These studies demonstrate that SEMA3F had a
repulsive effect on C100 cells, which express NRP1 and
NRP2, and that this effect was mediated by NRP2. On less
motile MCF7 cells, which only express NRP1, exposure to
SEMA3F led to disrupted intercellular contacts with delocal-
ization of E-cadherin and b-catenin. This effect was mediated
by NRP1. Moreover, MCF7 cells exposed to SEMA3F were
less proliferative, although they did not undergo apoptosis.
Materials and Methods
Plasmid Constructions and Cell Lines
SEMA3F cDNA was cloned into pSecTagA vector at the
3V end of the alkaline phosphatase gene (AP-SEMA3F) and
was generously provided by Dr. M. Tessier-Lavigne [4]. AP-
pSecTag (AP) expressed alkaline phosphatase as nega-
tive control. Stably transfected human embryonic kidney
293 cells (HEK 293 and ATTCC CRL 1573) expressing
functional recombinant Sema3A or Sema3C (pBKFlagSe-
ma3AP1b and pBKFlagSema3CP1b) [22–24] or mock-
transfected (control) cells were cultured in MEM plus 10%
fetal calf serum (FCS) and 1 mg/ml G418 (InVitrogen, Cergy
Pontoise, France). MCF7 cells were grown in RPMI 1640
containing 10% FCS (InVitrogen). C100 cells, derivatives of
MDA-MB-435S [25], were grown in 50% DMEM/50% Ham’s
F12 containing 10% FCS. COS7 cells were grown in DMEM
plus 10% FCS. Transfections of AP or AP-SEMA3F con-
structs were performed using Effecten (Qiagen, Courta-
boeuf, France) with conditions recommended by the
manufacturer. For transfected COS7 cells, the medium
was replaced 2 days after transfection by DMEM, containing
0.5% FCS or OPTIMEM media (InVitrogen). The medium
was collected 4 days after transfection and applied to
MCF7 and C100 cell cultures. SEMA3F concentration was
estimated by alkaline phosphatase activity (GenHunter,
Nashville, TN).
Coculture Assay
Semaphorin-expressing HEK 293 aggregates and tumor
cell aggregates were prepared as described previously [26].
Aggregates were placed in 20 ml of chicken plasma on glass
coverslips. During plasma coagulation with 20 ml of thrombin,
tumor cells aggregates were arranged around semaphorin-
secreting HEK 293 aggregates at 100- to 900-mm distances
(Figure 1A). After 30 to 45 minutes, the coverslips were
placed in Petri dishes with culture media and transferred to
an incubator (37jC, 5% CO2). Blocking experiments were
performed by incubating aggregates with 1.0 mg/ml anti-
NRP2 polyclonal antibody (Santa Cruz Biotechnology, Santa
Cruz, CA) or 1.0 mg/ml anti-NRP1 polyclonal antibody (On-
cogene, Darmstadt, Germany). After a 72-hour culture,
aggregates were fixed in 4% formaldehyde and analyzed.
In order to quantify the semaphorin effects, we assigned an
index factor varying between 2 and +2 for each aggregate
based on the number of tumor cells that migrated from the
aggregates. A positive or negative value was attributed to
aggregates when cancer cells migrated toward or away from
the semaphorin-secreting HEK 293 aggregate, respectively.
A null index was attributed to aggregates when no cells
escaped from the aggregates, or when cells escaped sym-
metrically (nondirectionally). Statistical significance between
the different mean values was examined using the chi-
square test.
Membrane Preparations and Stripe Assay
Membranes were prepared from ~1 106 HEK 293 cells
transiently transfected with AP, AP-SEMA3F, or cells stably
expressing Sema3A or Sema3C, as described [23,27,28].
Briefly, cells were washed in PBS and placed in homogeni-
zation buffer [10 mM Tris–HCl, pH 7.4, 1.5 mM CaCl2, 1 mM
spermidin, 25 mg/ml aprotinin, 25 mg/ml leupeptin (all from
COGER, Paris, France) and 15 mg/ml 2,3-dehydro-2-desoxy-
N-acetylneuraminic acid (Sigma-Aldrich, Saint Quentin
Fallavier, France)]. The homogenate was centrifuged for
10 minutes at 25,000g in a sucrose gradient (upper phase,
150 ml of 5% sucrose; lower phase, 500 ml of 50% sucrose in
PBS). The interband containing the membrane fraction was
collected and washed twice in PBS (without Ca2+ and Mg2+)
by spinning in a microfuge for 15 minutes at 13,000g. After
resuspension in PBS, the concentration of purified mem-
branes was determined by measuring the OD220 nm of
solutions diluted 15-fold in 2% SDS. Membrane preparations
were supplemented with 3-ml fluorescent beads (Cova-
spheres; Duke Scientific, Palo Alto, CA) per 100 ml of mem-
brane solution. One drop of membrane suspension was
pipetted onto a capillary pore filter connected to a vacuum
pump covered by a silicone matrix. Membranes were trans-
ferred onto the nylon matrix to form stripes. These stripes
(on capillary pore filters) were transferred to poly-L-lysine–
coated (1 mg/ml; Sigma-Aldrich) glass coverslips. The glass
coverslips were then transferred to Petri dishes containing
culture media. Finally, C100 and MCF7 cells were added to
the Petri dishes at a density of 2 105 cells/ml, cultured for
24 hours, and fixed with 4% formaldehyde. Blocking anti-
bodies (described above) were added for a period of 24
hours prior to fixing. Analysis of stripe assays was performed
using the Metaview 5.0 universal imaging system to drive the
motorized plate of an inverted microscope (Zeiss, Oberko-
chen, Germany). Cells on stripes and in the interstripe space
were counted and their mean values were analyzed statis-
tically using the chi-square test.
Immunostaining
Cells were fixed in 4% formaldehyde for 10 minutes and
then permeabilized using 0.1% Triton X-100 for 5 minutes at
room temperature. A first antibody was applied during 1 hour:
E-cadherin mouse monoclonal antibody (1:100) raised
against amino acids 735 to 863 (BD Biosciences, Saint
Quentin Fallavier, France) or b-catenin mouse monoclonal
antibody HRPO-linked (1:100) raised against amino acids
571 to 781 (BD Biosciences). A goat antimouse antibody
bound to CY3 (1:200; Interchim, Montluc¸on, France) was
used as a second antibody. Immunostained samples were
finally examined using the yellow line (568 nm) of the
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confocal microscope (BioRad, Hemel Hempstead, UK) as
described previously [12].
Western Blots
A total of 2.5  106 MCF7 and C100 cells were washed
twice with cold PBS, then lysed in 1 ml of lysis buffer [50 mM
Tris–HCl, pH 7.4, 150 mM NaCl, 0.05% NP-40 (wt/vol), 1%
DOC (wt/vol), 1% Triton X-100, 0.1% SDS, 1.25 mM PMSF,
20 mM leupeptin, 0.8 mM aprotinin, and 10 mM pepstatin]. The
amount of protein in each lysate was measured using the
BCA kit protocol (PerBio Sciences, Bezons, France). Fifty
micrograms of protein per well was resolved by 10% SDS-
PAGE followed by Western blotting. Equal loading was
verified by Coomassie staining of separately run gels and
by Western blotting with an anti–a-tubulin antibody. The
antibodies and dilutions were: anti–a-tubulin (mouse mono-
clonal, 1:1000 dilution; Sigma-Aldrich), E-cadherin (de-
scribed above, 1:2500), b-catenin (mouse monoclonal
raised against amino acids 571 to 781, HRPO-linked,
1:1000; BD Biosciences), N-cadherin (mouse monoclonal
antibody raised against a portion of the chick intracellular
domain, 1:5000; Clinisciences, Montrouge, France), and
sheep antimouse IgG (HRP-linked, 1:2000; Amersham
Pharmacia Biotechnologies, Buckinghamshire, UK). Detec-
tion was performed by ECL.
Apoptosis Assay
A total of 2105 cells were cultured for 2 days before an
additional 24-hour stimulation with 100 ng/ml AP-SEMA3F
in conditioned medium, or with an equivalent volume of
control AP medium. Apoptotic cells were visualized using
the TdT-mediated dUTP nick-end labeling (TUNEL) of DNA
fragments (apoptosis detection system, Fluorescein; Prom-
ega, Madison, WI). A positive apoptotic control was made by
Figure 1. SEMA3F had a repulsive effect on C100 cells that involved NRP2 receptor. Tumor cell aggregates (A and B, white circle) were arranged all around
control or semaphorin-secreting HEK 293 aggregates (A, black circle; B, black semicircle) in a three-dimensional plasma clot. Three major tumor cell migration
types could be observed after a 3-day incubation: a symmetrical migration (B, left drawing), a repulsion (B, top central drawing), or an attraction (B, right drawing).
C100 cell aggregates were placed in front of HEK 293 aggregates transfected with AP construct (C, control), AP-SEMA3F (D–F), Sema3A (G), or Sema3C (H). In
some cases, C100 cells were treated during 3 days with anti-NRP1 (E) or anti-NRP2 (F) antibodies. (I) and (J) are a higher magnifications of the dashed squares
represented in (D) and (E), respectively, showing C100 cells escaping from the more distal parts of the aggregates from the SEMA3F source. C100 aggregates are
represented by a black dashed line (B–J) and are surrounded by C100 migrating cells. Secreting HEK 293 aggregates are delimited by a black drawing (C–H). In
(F), an inset of escaping cells is shown at the bottom right. C100 aggregates are entirely represented, but only a part delimited by the black drawing is shown for
secreting HEK 293 aggregates (C–H). Scale bar = 200 m.
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treating cells for 16 hours with 1.5 mM staurosporin. Fluores-
cein labelling was examined using the blue line (488 nm) of
the confocal microscope. Nuclei were also stained after
fixation using 50 mg/ml propidium iodide (Sigma-Aldrich).
Staining was observed using the yellow line (568 nm) of
the confocal microscope. Nonapoptotic (PI-positive) and
apoptotic (PI- and fluorescein-positive cells) cells were
counted and statistical analysis was performed using the
Student’s t test.
Cell Proliferation Test
A total of 1 105 cells were treated with either 100 ng/ml
AP-SEMA3F in conditioned medium or with control AP
medium, and were cultured for 24 hours in the incubation
chamber of a motorized microscope (Zeiss). Microcinema-
tography was performed using the Metaview 5.0 universal
imaging system. Statistical analysis was performed using the
Student’s t test.
Quantitative Reverse Transcription Polymerase Chain
Reaction (RT-PCR)
Total RNA was extracted using the Rneasy Mini kit
(Qiagen). RT-PCRwas performed with Superscript II reverse
transcriptase (InVitrogen) using the procedure supplied by
the manufacturer. We assessed levels of E-cadherin mRNA
normalized to GAPDH by quantitative real-time PCR carried
out with the ABI 7000 (Applied Biosystems, Courtaboeuf,
France) system using SYBR-Green chemistry. The cycle at
which a particular sample reaches an arbitrary threshold fluo-
rescent level (Ct) is indicative of the amount of input template.
The following E-cadherin primers were used: Ecadh For (5V
CGG GAA TGC AGT TGA GGA TC 3V), Ecadh Rev (5V-AGG
ATGGTG TAAGCGATGGC-3V).GAPDH cDNA was ampli-
fied with primers GAPDH For (5V-TGC-ACC-ACC-AAC-
TGC-TTA-GC-3V) and GAPDH Rev (5V-GGC-ATG-GAC-
TGT-GGT-CAT-GAG-3V). The PCR was carried out in
20-ml reaction volumes consisting of 1  PCR SYBR Green
buffer, 0.125 mM of primers, 200 mM of each dNTP, 2 mM
MgCl2 and 0.025 U/ml AmpliTaq Gold (Applied Biosystems).
cDNA was amplified as follows: 50jC for 2 minutes, 95jC for
10 minutes followed by 35 cycles at 95jC for 15 seconds,
60jC for 1 minute.
Results
SEMA3F Exhibits Repulsive Activities Toward C100
Migration
C100 cells are highly motile and grow in a dispersed
fashion [12]. These cells express both NRP1 and NRP2, but
only low levels of SEMA3F are measured by real-time
quantitative RT-PCR [12]. To determine whether SEMA3F
affected C100 migration, we applied the three-dimensional
coculture guidance assay in which tumor cell aggregates
and HEK 293 aggregates secreting either alkaline
phosphatase–tagged SEMA3F (AP-SEMA3F) or alkaline
phosphatase alone (AP control) were incubated in close
proximity (Figure 1A). After a 3-day incubation, each aggre-
gate was observed and virtually subdivided in quadrants
(Figure 1B). When tumor cells migrated homogenously in all
Figure 2. Quantification of the repulsive effect of SEMA3F on C100 cell migration. A positive or a negative index varying between +2 and 2 was attributed to each
C100 aggregate when tumor cells migrate toward or away from the source of semaphorin, respectively (see Materials and Methods section and Figure 1). A mean
index factor was calculated for each condition and was represented as a bar graph. n = number of analyzed aggregates.
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quadrants (Figure 1B, left condition) or when there was no
migration in all quadrants, we considered that there was no
migratory effect of HEK 293 aggregates and an arbitrary null
index factor was attributed. On the contrary, when cells
migrated in the two most distal quadrants (Figure 1B, top
central condition) or the two most proximal quadrants from
HEK 293 aggregates (Figure 1B, right condition), we con-
sidered that there was a repulsion or an attraction, respec-
tively, and we attributed to these aggregates a negative or a
positive index factor.
After 3 days, C100 cells migrated all around the tumor
aggregate in an apparent random or diffuse manner with
the AP control HEK 293 aggregates (Figures 1C and 2). In
contrast, the C100 cells did not migrate in the direction of the
AP-SEMA3F–expressing HEK 293 aggregates but only
escaped from the most distant part of the tumor aggregate
(Figures 1, D and I and 2). This effect was strongly inhib-
ited by anti-NRP2 antibodies (Figures 1F and 2), whereas
no differences were observed with anti-NRP1 antibodies
(Figures 1, E and J and 2). In addition, C100 migration was
not affected by HEK 293 aggregates expressing Sema3A
or Sema3C (Figures 1, G and H and 2).
To confirm these results using a complementary ap-
proach, we implemented a stripe assay developed by Walter
et al. [29]. SEMA3F was immobilized on poly-L-lysine–
coated glass coverslips in alternating stripes consisting of
membranes derived from AP-SEMA3F-transfected HEK 293
cells. The interstripe spaces contained only the culture
medium. Secreted SEMA3F is able to interact with membra-
nous lipids by haptotactism through its positively charged C-
terminus [23]. Control stripes were derived from membranes
of HEK 293 cells transfected with the control vector (AP). The
coverslips were overlaid with C100 cells, then after a 24-hour
incubation, cells were fixed and counted.
By time lapse microscopy, we observed that C100 cells
initially attached equally on stripes and interstripes. Subse-
quently, however, C100 cells preferentially migrated to the
interstripe region when the stripes were derived from AP-
SEMA3F–transfected HEK 293 cells (Figures 3B and 4).
Most of the cells aligned at the stripe borders but did not
penetrate into the stripes. As noted above with the three-
dimensional culture system, this effect was not modified by
an anti-NRP1 antibody (Figures 3D and 4), but was com-
pletely inhibited by an anti-NRP2 antibody (Figures 3F and
4). Similarly, stripes derived from Sema3A- and Sema3C-
transfected HEK 293 cells had no significant effect on C100
migration (Figures 3,G and H and 4). Thus, we conclude that
SEMA3F has a specific repulsive activity on the migration of
C100 cells, which is mediated by NRP2.
SEMA3F Actions on MCF7 Cells
MCF7 cells grow in tight clusters, are much less motile
than C100, and express NRP1 but not NRP2 [12]. In the
three-dimensional coculture assay, no differences in MCF7
migration were seen when these cells were placed in prox-
imity to either the control or SEMA3F-expressing HEK 293
aggregates (data not shown). We were surprised by this
result because we previously observed that exposure to
SEMA3F resulted in loss of lamellipodia and cell attachment,
which was mediated by NRP1 [12]. Importantly, it shows that
SEMA3F is not able to promote the motility of MCF7 cells,
on the contrary to HGF/SF, which enhances the invasive
potential and scattering of these cells [30]. In the three-
dimensional coculture assay, Sema3A and Sema3C had a
tendency to attract MCF7 cells (data not shown). In the
SEMA3F stripe assay, MCF7 cells were equally distributed
between the stripe and interstripe regions (data not shown).
Likewise, no differences were noted when the stripes were
derived from Sema3A- or Sema3C-expressing cells. It is
possible that the lack of demonstrable migration inhibition by
SEMA3F is due to the absence of NRP2 or because MCF7
Figure 3. C100 cells escaped from SEMA3F in a stripe assay. Membranes
from HEK 293 cells transfected with AP (A, C, and E, control), AP-SEMA3F
constructs (B, D, and F), Sema3A (G), or Sema3C (H) were used to make
stripes on glass coverslips. Cells were spread and cultured for 24 additional
hours with anti-NRP1 (C and D) or anti-NRP2 (E and F) antibodies.
Presence or absence of semaphorin is indicated by (+) or (), respectively.
Scale bar = 100 m.
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cells are poorly motile. We have not further investigated this
issue, although we did confirm that SEMA3F negatively
affects the growth of MCF7 cells.
MCF7 cells in islets were observed by time lapse video-
microscopy during a 24-hour period under exogenous
SEMA3F treatment. We found that SEMA3F-treated islets
extended less than control islets (Figure 5) and that fewer
cells were present in SEMA3F-treated islets compared to
control (doubling time 42.2 vs 25.5 hours for control cells)
(Figure 6). Despite their abnormal shape, these cells did not
undergo apoptosis using a TUNEL assay (data not shown).
SEMA3F Inhibits E-Cadherin–Mediated Adhesion
MCF7 cells grow in islets and exhibit numerous inter-
cellular contacts. However, when exposed to exogenous
SEMA3F, loss of cell–cell contacts was evident by 12 hours
and persisted through 24 hours of observation. The cells
retracted, became smaller, and detached from each other
(Figure 5, third row). These observations are very similar to
the disruption of epithelial tumor cell–cell adhesion caused
by HGF/SF [31]. However, on SEMA3F treatment, no scat-
tering was observed after cell detachment. No loss of cell–
cell contacts was observed in the control-treated cells. The
SEMA3F effects were inhibited by an anti-NRP1 antibody
(Figure 5, fourth row).
Because of these results, we looked for changes in
selected proteins known to affect intercellular adhesion, with
E-cadherin being an obvious candidate in epithelial-derived
cells. In control MCF7 cells, E-cadherin membrane staining
was observed at cell junctions (Figure 7A). On treatment with
exogenous SEMA3F, loss in E-cadherin staining was evident
after 2 hours (data not shown). After 24 hours, membranous
E-cadherin staining was nearly completely lost, although a
granular cytoplasmic staining was observed (Figure 7B).
This effect was inhibited by an anti-NRP1 antibody
(Figure 7, C and D). By Western blot, approximately 80%
of the E-cadherin signal was lost after 24 hours (Figure 8),
although no changes in E-cadherin mRNA were detected by
quantitative RT-PCR (data not shown). By immunofluores-
cence, b-catenin staining was also reduced (Figure 7, E and
F ) by SEMA3F, although no loss was detected by Western
blot (Figure 8). During tumor progression, loss of E-cadherin
has been associated with increased expression of N-
cadherin [32], so-called ‘‘cadherin switching’’ [33–35]. How-
ever, N-cadherin, which was not expressed in control MCF-7
cells, was not induced following exposure to SEMA3F
(Figure 8).
Discussion
We previously reported that SEMA3F was able to inhibit the
attachment and spreading of breast cancer cell lines as
evidenced by loss of lamellipodia extensions when cells
were grown in a SEMA3F-positive medium [12]. Because
semaphorins affect directional migration during neural de-
velopment, as neurobiologists, we applied similar methods to
the analysis of tumor cell directional migration in a SEMA3F-
positive environment. We developed the three-dimensional
coculture assay where tumor cells faced a SEMA3F gradi-
ent. Coculture assays are widely used to detect repellent
activities of semaphorins/collapsins in the nervous system
[2,23,26], and to study other activities such as cardiac
morphogenesis [36]. This approach was completed by stripe
assays [23,24,37,38], where cells have the choice to migrate
inside or outside a SEMA3F-containing stripe. This assay
has been used by neurobiologists to study nerve growth
cone guidance, but, to our knowledge, has never been
applied by other groups to study migration of cancer cells.
Although we used stripes composed of membranes from
SEMA3F-transfected HEK 293 cells, stripes can obviously
Figure 4. Quantification of C100 cells escaping from SEMA3F. The mean number of C100 cells on stripes (where there is a source of SEMA3F) was calculated
from stripe experiments as described in Figure 3 and represented as a histogram with or without anti-NRP1 and anti-NRP2 antibodies. Three independent
experiments were performed.
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Figure 5. MCF7 cells retracted and lost cell contacts on SEMA3F treatment. Islets of control (AP) or SEMA3F-treated (AP-SEMA3F) MCF7 cells in the absence or
presence of anti-NRP1 antibody were observed by contrast phase microscopy and microcinematography at time 0, 12, and 24 hours. Scale bar = 100 m.
Figure 6. Proliferation of MCF7 was reduced on SEMA3F treatment. MCF7 control or SEMA3F-treated cells were counted over a period of 24 hours by
microcinematography on selected islets. SEMA3F treatment was performed at time 1 hour. Dark dots, control cells; white dots, SEMA3F-treated cells.
186 Migration and Adhesion Inhibition by SEMA3F Nasarre et al.
Neoplasia . Vol. 7, No. 2, 2005
be derived from any cellular source; hence, they are useful
for the study of tumor–normal attachment/invasion. We
believe that these assays reflect more the in vivo situation
where cancer cells develop and escape from tissues pre-
senting a nonhomogenous SEMA3F concentration.
Highly motile C100 cells responded to a gradient of
SEMA3F in the coculture assay by not escaping from the
aggregates toward the SEMA3F source. This result indicates
that either SEMA3F inhibits motility, or has a repulsive
activity on cell motility. The results of the stripe assay were
most consistent with repulsion because, first, the cells at-
tached equally to the stripe and interstripe regions (data not
shown) and then migrated to the interstripes. Antibodies
against NRP2 blocked these effects, which is consistent with
the demonstrated role of NRP2 in SEMA3F signaling. How-
ever, MCF7 cells did not respond to SEMA3F by these two
tests. This may be due to the fact that these cells already
express SEMA3F [12], are not motile, exhibit numerous
intercellular contacts, and express barely detectable levels
of NRP2 [12]. However, exposure of these cells to exoge-
nous SEMA3F reduced their ability to expand, which was
dependent on NRP1 [12].
In addition to these results, we found in MCF7 cells that
intercellular contacts were disrupted by SEMA3F and that
Figure 7. SEMA3F-treated MCF7 lost membranous E-cadherin and this effect was mediated by NRP1. Observations of control (A and C) or SEMA3F-treated
(B and D) MCF7 cells stained by immunofluorescence with an anti –E-cadherin antibody. Incubation with an anti-NRP1 antibody was performed during 1.5 hours
(C and D). -Catenin staining was performed for control (E) or SEMA3F-treated cells (F). Cultures were treated for 24 hours with control AP or AP-SEMA3F
media. Scale bar = 50 m.
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this was associated with loss of membranous E-cadherin
and its delocalization to the cytoplasm. Initial events in the
metastatic spreading of tumors involve loss of cell–cell
adhesion within the primary tumor mass. Loss of membra-
nous E-cadherin was NRP1-dependent. Although NRP2 was
reported to be the only functional receptor for SEMA3F in the
nervous system [39], SEMA3F also binds NRP1 albeit at 10-
fold less affinity than NRP2 [4]. This low affinity for NRP1
could explain why MCF7, already expressing SEMA3F, is
sensitive to extra SEMA3F. As to the mechanism of E-
cadherin loss, we can only speculate at present. Endocytosis
of E-cadherin has been observed during mitosis, after HGF-
induced cell scattering, and after depletion of extracellular
calcium [40–42]. Similarly, Sema3A has been shown to
induce endocytosis at sites of membrane retraction [43]
and this effect is mediated by L1-CAM association to
NRP1–Plexin A1 complex [44]. Thus, SEMA3F could con-
ceivably affect endocytosis. Perhaps a more likely mecha-
nism involves changes in activated surface integrins as
semaphorins from class 3 have recently been shown to
downregulate activated surface integrins [8]. Interestingly,
activation of the repulsive receptor Roundabout inhibits N-
cadherin–mediated cell adhesion [45]. Roundabout is the
receptor for Slit, another secreted guidance cue, and it was
shown that Slit2 is frequently inactivated in colorectal cancer
and suppresses the growth of colorectal carcinoma cells
[46]. Therefore, cadherin adhesion appears to be inhibited
by two guidance molecules, SEMA3F and Slit2. On a cau-
tionary note, we have not yet studied the effects of SEMA3F
on E-cadherin on surfaces other than tissue culture plastic-
ware and we do not know how these in vitro changes might
reflect in vivo effects.
However, loss of E-cadherin is not sufficient by itself to
induce metastasis and it has to be associated with increase
in N-cadherin level in breast cancer cells. In fact, N-cadherin
promotes motility regardless of E-cadherin expression [32].
N-cadherin stimulation did not occur in MCF7 on SEMA3F
treatment. In addition, the loss of MCF7 cell–cell contacts is
clearly not associated with increased cell motility and prolif-
eration. Thus, loss of E-cadherin would not favor tumor
metastasis in our system.
We also examined b-catenin localization in SEMA3F-
treated MCF7 cells because cadherin cytoplasmic domains
provide F-actin cytoskeleton attachment points through the
association of catenins and other cytoskeletal associated
proteins. In addition, b-catenin has been shown to function
as a downstream transcriptional activator of the Wnt/Wing-
less signaling pathway during morphogenesis and tumori-
genesis [47]. Accompanying E-cadherin loss following
SEMA3F treatment, we noticed apparent delocalization of
b-catenin from the membrane, although the total protein
levels did not change as determined by Western blot. This
observation is not surprising as a net loss of F-actin has
been described at the leading edge of the growth cones
when exposed to collapsing factor [48]. In addition, the Wnt/
Wingless pathway could be affected as glycogen synthase
kinase (GSK-3) is activated by Sema3A at the leading edge
of growth cones [49].
In summary, SEMA3F has a repulsive effect on motile
C100 cells, which is mediated by NRP2. On low motile
MCF7 cells, SEMA3F induces loss of cellular contacts
with partial delocalization of E-cadherin and b-catenin, but
does not promote cell scattering. These changes were
associated with a decrease in cell proliferation. In cells
that express NRP1 but not NRP2, NRP1 is a functional
receptor for SEMA3F. We hypothesize that secreted sem-
aphorins might function in the maintenance of boundaries.
In cancer, loss of this function has been shown to en-
hance cell migration and it appears that opposing auto-
crine loops involving VEGF and semaphorins can regulate
chemotactic activity [50]. These results support the con-
cept that, in a first step during tumorigenesis, normal
tissues expressing SEMA3F would try to prevent tumor
cells from spreading and attaching to the stroma cells for
further implantation.
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